Clinical Trials in Nashville

Showing 11381-11400 of 17,403 trials

Adipose-derived SVF for Treatment of Alopecia

NCT02626780

The general objective of this study is to conduct a safety and feasibility study of a single injection of autologous adipose-derived SVF for the treatment of alopecia.

Androgenetic Alopecia

GID BIO, Inc.7 participantsStarted Jul 2016

Nashville, Tennessee, United States • San Antonio, Texas, United States

COMPLETEDPhase 1/2< 1 mile

Study of Oral IXAZOMIB in Combination With Lenalidomide and Dexamethasone in Participants With Newly Diagnosed Multiple Myeloma

NCT01383928

The purpose of this study is to determine the safety, tolerability, maximum tolerated dose (MTD), and recommended phase 2 dose (RP2D) in phase 1 and to determine the combined response rate of clinical response CR and very good partial response (VGPR) in phase 2 of oral (PO) ixazomib administered twice-weekly in combination with lenalidomide and low-dose dexamethasone in a 21-day cycle in participants with newly diagnosed multiple myeloma (NDDM).

Multiple Myeloma

Millennium Pharmaceuticals, Inc.64 participantsStarted Oct 2011

Berkeley, California, United States • Duarte, California, United States • Stanford, California, United States +17 more locations

Adipose-derived SVF for Treatment of Alopecia

Study of Oral IXAZOMIB in Combination With Lenalidomide and Dexamethasone in Participants With Newly Diagnosed Multiple Myeloma

Find Trials by Condition in Nashville

DF4 Connector System Post-Approval Study

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Phase IIIb Study of APD421 in Combination as PONV Prophylaxis

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary Cirrhosis

Investigational Device Exemption Study to Determine the Safety and Efficacy of the Astron and Pulsar Stents

A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer

Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II)

Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome

Persistent Pulmonary Hypertension of the Newborn (PPHN) Observational Study

Ruxolitinib Prior to Transplant in Patients With Myelofibrosis

A Study of LY3113593 in Participants With Chronic Kidney Disease

Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)

Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination

Use of the VisuMax™ Femtosecond Laser

UroLift System TOlerability and ReCovery When Administering Local Anesthesia

Post-eRADicAte - A Long Term Follow up of Subjects That Completed the eRADicAte Study (NCT 02097303)

A Study of E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 and/or Ras Mutations